High
1.330
Open
1.250
VWAP
1.28
Vol
404.18K
Mkt Cap
71.84M
Low
1.2492
Amount
516.34K
EV/EBITDA(TTM)
--
Total Shares
47.94M
EV
61.45M
EV/OCF(TTM)
--
P/S(TTM)
18.78
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q2
FY2025Q1
914.00K
+38.07%
-0.070
-12.5%
975.50K
-3.51%
-0.065
+8.33%
750.00K
+0.94%
-0.080
-0%
Estimates Revision
The market is revising Downward the revenue expectations for IceCure Medical Ltd (ICCM) for FY2025, with the revenue forecasts being adjusted by -14.82% over the past three months. During the same period, the stock price has changed by 1.60%.
Revenue Estimates for FY2025
Revise Downward
-14.82%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+6.67%
In Past 3 Month
Stock Price
Go Up
+1.60%
In Past 3 Month
2 Analyst Rating
116.54% Upside
Wall Street analysts forecast ICCM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ICCM is 2.75 USD with a low forecast of 2.50 USD and a high forecast of 3.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
116.54% Upside
Current: 1.270
Low
2.50
Averages
2.75
High
3.00
116.54% Upside
Current: 1.270
Low
2.50
Averages
2.75
High
3.00
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$2.5
2025-03-28
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$2.5
2025-03-28
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$2.5
2024-11-27
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$2.5
2024-11-27
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$2.5
2024-11-08
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$2.5
2024-11-08
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$2.5
2024-09-12
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$2.5
2024-09-12
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Maintains
$3 → $2.5
2024-08-21
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$3 → $2.5
2024-08-21
Maintains
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$3
2024-07-02
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$3
2024-07-02
Reiterates
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Icecure Medical Ltd (ICCM.O) is -4.57, compared to its 5-year average forward P/E of -5.28. For a more detailed relative valuation and DCF analysis to assess Icecure Medical Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-5.28
Current PE
-4.57
Overvalued PE
2.24
Undervalued PE
-12.79
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
14.86
Current PS
10.68
Overvalued PS
30.98
Undervalued PS
-1.26
Financials
Annual
Quarterly
FY2024Q4
YoY :
-30.28%
875.00K
Total Revenue
FY2024Q4
YoY :
+32.50%
-4.53M
Operating Profit
FY2024Q4
YoY :
+49.55%
-4.48M
Net Income after Tax
FY2024Q4
YoY :
+14.29%
-0.08
EPS - Diluted
FY2024Q4
YoY :
+76.10%
-4.20M
Free Cash Flow
FY2024Q4
YoY :
+5.12%
47.66
Gross Profit Margin - %
FY2024Q4
YoY :
-4.86%
-383.90
FCF Margin - %
FY2024Q4
YoY :
+114.49%
-511.89
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ICCM News & Events
Events Timeline
(ET)
2025-03-24
08:34:37
IceCure Medical announces interim results from ICESECRET study
2025-03-20 (ET)
2025-03-20
08:34:12
IceCure Medical in discussions with FDA on marketing request for ProSense
2025-03-17 (ET)
2025-03-17
08:35:34
IceCure Medical receives Notice of Allowance from CNIPA
Sign Up For More Events
Sign Up For More Events
News
Preview
1.0
04-28PRnewswireIceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium
Preview
9.0
04-22PRnewswireIceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation
Preview
4.0
03-28BenzingaHC Wainwright & Co. Reiterates Buy on Icecure Medical, Maintains $2.5 Price Target
Sign Up For More News
People Also Watch
LAAC
Lithium Americas (Argentina) Corp
2.740
USD
0.00%
NWPX
Northwest Pipe Co
42.880
USD
+1.23%
CLW
Clearwater Paper Corp
25.010
USD
+2.25%
RDVT
Red Violet Inc
39.320
USD
+4.35%
EVLV
Evolv Technologies Holdings Inc
4.100
USD
-1.44%
SENS
Senseonics Holdings Inc
0.750
USD
+3.88%
AIRJ
Montana Technologies Corp
5.070
USD
+1.60%
GHM
Graham Corp
30.480
USD
-1.30%
ANGO
AngioDynamics Inc
9.580
USD
+0.63%
SVRA
Savara Inc
3.260
USD
+2.19%
FAQ
What is Icecure Medical Ltd (ICCM) stock price today?
The current price of ICCM is 1.27 USD — it has increased 4.1 % in the last trading day.
What is Icecure Medical Ltd (ICCM)'s business?
What is the price predicton of ICCM Stock?
What is Icecure Medical Ltd (ICCM)'s revenue for the last quarter?
What is Icecure Medical Ltd (ICCM)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Icecure Medical Ltd (ICCM)'s fundamentals?
How many employees does Icecure Medical Ltd (ICCM). have?